News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Amplia.
RELATED STOCKHEAD STORIES
Health & Biotech
Which cancer-fighting biotech will be the next Race Oncology?
Experts
ScoPo’s Health Powerplays: The money keeps flowing for the ASX biotechs
Health & Biotech
Zelira Therapeutics to launch cannabis-based toothpaste
Health & Biotech
The 6 ASX small cap biotechs that have more than doubled in 2020
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Health: Amplia really gives a FAK about cancer as phase 1 trial still on track
Health & Biotech
Check up: Making it in America
Health & Biotech
Cyclopharm says radioactive gas could help diagnose COVID-19
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Cancer Wars Part 1: These are the ASX small cap drugmakers that want to conquer cancer
Director Trades
Directors Trades: The company that has risen 12,000pc and directors keep buying more
Health & Biotech
Check-up: here’s the latest with the ASX small cap health stocks
Health & Biotech
